Cargando…
A Contemporary Report of Clinical Outcomes in Patients with Melanoma Brain Metastases
Background: Brain metastases are observed in more than 40% of all patients with stage 4 melanoma. In recent years, more extensive use of stereotactic radiation (STRT) and the advent of immune checkpoint inhibitors have positively impacted outcomes in patients with metastatic melanoma.brain metastase...
Autores principales: | Phillips, William J., Baghai, Tabassom, Ong, Michael, Lo, Bryan, Ibrahim, Andrea M., Smith, Tyler K. T., Song, Xinni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903273/ https://www.ncbi.nlm.nih.gov/pubmed/33450821 http://dx.doi.org/10.3390/curroncol28010045 |
Ejemplares similares
-
Contemporary Neoadjuvant Therapies for High-Risk Melanoma: A Systematic Review
por: Boulva, Kerianne, et al.
Publicado: (2021) -
Outcomes of Treatment for Melanoma Brain Metastases
por: Janavicius, Mantas, et al.
Publicado: (2020) -
Contemporary Management of 1–4 Brain Metastases
por: Sittenfeld, Sarah M. C., et al.
Publicado: (2018) -
Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy
por: Vasudevan, Harish N., et al.
Publicado: (2023) -
Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
por: Jiang, Cecilia, et al.
Publicado: (2021)